Li, J.; Hu, Z.; Zhu, J.; Lin, X.; Gao, X.; Lv, G.
Antitumor Effects of Pegylated Zinc Protoporphyrin-Mediated Sonodynamic Therapy in Ovarian Cancer. Pharmaceutics 2023, 15, 2275.
https://doi.org/10.3390/pharmaceutics15092275
AMA Style
Li J, Hu Z, Zhu J, Lin X, Gao X, Lv G.
Antitumor Effects of Pegylated Zinc Protoporphyrin-Mediated Sonodynamic Therapy in Ovarian Cancer. Pharmaceutics. 2023; 15(9):2275.
https://doi.org/10.3390/pharmaceutics15092275
Chicago/Turabian Style
Li, Jia, Zheng Hu, Jiwei Zhu, Xin Lin, Xu Gao, and Guixiang Lv.
2023. "Antitumor Effects of Pegylated Zinc Protoporphyrin-Mediated Sonodynamic Therapy in Ovarian Cancer" Pharmaceutics 15, no. 9: 2275.
https://doi.org/10.3390/pharmaceutics15092275
APA Style
Li, J., Hu, Z., Zhu, J., Lin, X., Gao, X., & Lv, G.
(2023). Antitumor Effects of Pegylated Zinc Protoporphyrin-Mediated Sonodynamic Therapy in Ovarian Cancer. Pharmaceutics, 15(9), 2275.
https://doi.org/10.3390/pharmaceutics15092275